Pascale SATTONNET-ROCHE
Mme Pascale SATTONNET-ROCHE
Laborantine
A08.2919.b
+41 22 37 95 772
E-mail
After completing a scientific baccalaureate, Pascale Sattonnet-Roche obtained a diploma as a biomedical analysis technician at the Pasteur Institute in Lyon.
For 10 years, while working in the immunohistopathology laboratory of the dermatology department at Ed. Herriot Hospital in Lyon, she collaborated with the Inserm209 and CNRS801 units, resulting in approximately twenty scientific articles in immunodermatology.
Upon arriving in Geneva in 1992, her position at the Battelle Foundation led to her certification by the veterinary office as an "in vivo" technician in pharmacology and behavior.
Following the closure of the foundation, she joined the pharmaceutical research site Glaxo in 1996, which was later sold to Serono in 1998 and then to Merck Serono in 2007. Until the definitive closure of the research site in 2013, she gained significant experience in immunology and neurology. This included "in vitro" techniques such as establishing a bio-imaging platform, as well as "in vivo" techniques involving the management of transgenic animals (ApoE), surgical techniques, production and studies of "in vivo" proteins through electroporation of DNA of interest, and the establishment of various disease models such as pulmonary fibrosis, rheumatoid arthritis (AIA, CIA), and multiple sclerosis.
From 2013 until September 2020, she held various fixed-term contracts in private or public medical analysis laboratories (HUG and CHUV), as well as in university research (Science 3, Prof. Duboule, and CMU Prof. C. Gabay).
Since September 2020, she has been part of Isabella Eckerle's group in collaboration with the FIND Foundation in the context of the COVID pandemic for the evaluation of numerous rapid antigen tests and PCR kits. She collaborates with scientists from the research group at CMU and HUG.